NVO R&D to Revenue
Novo Nordisk A/S Common Stock · R&D to Revenue
NVO R&D to Revenue
Latest reported22.66%period ending
NVO Quarterly R&D/Revenue (0.00% → 22.66%)
Latest values, visible window
High-resolution chart · PNG
NVO r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 22.6621% | |
| 10.6214% | |
| 18.508% | |
| 20.5306% | |
| 15.2101% | |
| 13.2007% | |
| 16.1082% | |
| 13.3051% | |
| 23.7526% | |
| 13.1693% | |
| 15.8815% | |
| 13.8394% | |
| 13.1252% | |
| 12.607% | |
| 16.8115% | |
| 12.3623% | |
| 12.4149% | |
| 12.3861% | |
| 14.6923% | |
| 11.9364% | |
| 11.9367% | |
| 11.6673% | |
| 13.9492% | |
| 12.6459% | |
| 10.9678% | |
| 11.1498% | |
| 13.5238% | |
| 11.8935% | |
| 11.8425% | |
| 9.1427% | |
| 15.2832% | |
| 13.1259% | |
| 12.0261% | |
| 12.332% | |
| 14.2291% | |
| 12.5047% | |
| 11.9212% | |
| 11.5598% | |
| 15.1156% | |
| 12.5576% | |
| 12.1308% | |
| 12.1417% | |
| 13.9701% | |
| 12.2761% | |
| 11.2162% | |
| 12.8968% | |
| 15.721% | |
| 16.4232% | |
| 14.217% | |
| 15.5729% | |
| 16.4347% | |
| 13.6268% | |
| 12.6988% | |
| 13.2963% | |
| 15.3134% | |
| 13.1872% | |
| 13.1652% | |
| 14.1231% | |
| 15.1876% | |
| 13.6886% | |
| 14.5178% | |
| 14.5925% | |
| 16.9623% | |
| 14.7716% | |
| 15.8114% | |
| 15.5843% | |
| 18.2744% | |
| 15.0515% | |
| 14.222% | |
| 13.9542% | |
| 19.351% | |
| 14.0434% | |
| 17.8252% | |
| 17.4978% | |
| 31.1097% | |
| 16.4179% | |
| 16.6059% | |
| 16.7709% | |
| 18.2368% | |
| 15.5215% | |
| 15.4169% | |
| 15.8872% | |
| 16.442% | |
| 13.9732% | |
| 14.4345% | |
| 15.269% | |
| 16.2083% | |
| 14.4346% | |
| 14.576% | |
| 15.7407% | |
| 16.0647% | |
| 15.6546% | |
| 15.4382% | |
| 15.9598% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |